C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2011
11/08/2011	US8053092 m-carbazolylphenyl compounds
11/08/2011	CA2618393C Bis-aryl amide compounds and methods of use
11/08/2011	CA2529126C Azetidine compounds
11/08/2011	CA2509982C N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
11/08/2011	CA2493436C Indolinone derivatives, substituted in the 6-position, their preparation and their use as medicaments
11/08/2011	CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/08/2011	CA2405408C Pyrazole compounds
11/03/2011	WO2011137088A1 Herbicidal uracils
11/03/2011	WO2011136510A2 Novel method for preparing losartan metabolite exp-3174 dihydrate
11/03/2011	WO2011136292A1 Novel amide derivative and use thereof as medicine
11/03/2011	WO2011136264A1 [5,6] heterocyclic compound
11/03/2011	WO2011136247A1 Novel heteroaryl monocyclic pyrimidine derivative
11/03/2011	WO2011135520A1 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders
11/03/2011	WO2011135376A1 Pyrazolyl quinazoline kinase inhibitors
11/03/2011	WO2011135355A1 3-{ [5 -(azetidin-1-ylcarbonyl)pyrazin-2 -yl] oxy} -5-{ [(1s) -2 -hydroxy- 1 -methylethyl]oxy} -n- (5 -methylpyrazin-2-) benzamid monohydrate
11/03/2011	WO2011134140A1 Pyrimidinyl indole compounds
11/03/2011	WO2011134019A1 Novel biphenyl sartans
11/03/2011	WO2011098408A3 Hydrazine-substituted anthranilic acid derivatives
11/03/2011	WO2011075699A3 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/03/2011	WO2011062437A3 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
11/03/2011	WO2010052569A8 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110269973 Process for Preparing Dithiine-tetracarboximides
11/03/2011	US20110269960 Triazole derivative
11/03/2011	US20110269956 Hepatitis C Virus Inhibitors
11/03/2011	US20110269806 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
11/03/2011	US20110269783 Novel 2,3-diamino-quinazolinone derivatives and their medical use
11/03/2011	US20110269772 Axl kinase inhibitors
11/03/2011	US20110269770 Pyrazole Compounds for Controlling Invertebrate Pests
11/03/2011	US20110269769 Imidazole derivatives useful as inhibitors of faah
11/03/2011	US20110269768 Urotensin ii receptor antagonists
11/03/2011	US20110269765 Pyridazinone derivatives
11/03/2011	US20110269761 Arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
11/03/2011	US20110269760 Tubulin inhibitors
11/03/2011	US20110269759 Pyrimidine compounds as delta opioid receptor modulators
11/03/2011	US20110269753 Heterocyclic compounds as phosphodiesterase inhibitors
11/03/2011	US20110269745 6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
11/03/2011	US20110269742 Serotonin 5-HT2B Receptor Inhibitors
11/03/2011	US20110269737 7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases
11/03/2011	US20110269732 Drug discovery methods
11/03/2011	US20110269652 Gemini surfactants
11/03/2011	US20110268697 Hepatitis C Virus Inhibitors
11/03/2011	CA2797808A1 Piperazinotriazines as pi3k inhibitors for use in the treatment of antiproliferative disorders
11/03/2011	CA2791020A1 [5,6] heterocyclic compound
11/02/2011	EP2383269A2 Substituted Dihydropyrazolones for the treatment of cardiovascular diseases
11/02/2011	EP2383267A1 Substituted sulfonamide derivatives
11/02/2011	EP2383259A1 New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds
11/02/2011	EP2382215A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
11/02/2011	EP2382207A2 Pi3k/mtor kinase inhibitors
11/02/2011	EP2382194A2 Compounds for the prevention and treatment of cardiovascular disease
11/02/2011	EP2381943A1 Substituted quinazoline compounds
11/02/2011	EP2381941A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
11/02/2011	EP2381775A1 Small molecule inhibitors of necroptosis
11/02/2011	EP1732901B1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
11/02/2011	CN102232071A Fused multicyclic compounds as protein kinase inhibitors
11/02/2011	CN102232070A Synthesis and novel salt forms of (R)-5-((E)-2-(pyrrolidin-3-ylvinyl)pyrimidine
11/02/2011	CN102229605A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/02/2011	CN102229589A N-{4'-substituted piperazine-1-sulfonylmethylalkyl}-N-hydroxyfomamide compounds as metalloproteinase inhibitors
11/02/2011	CN101837302B Method for preparing chiral imidazolinone ionic liquid catalyst
11/01/2011	US8049032 Solid acid, polymer electrolyte membrane including the same, and fuel cell using the polymer electrolyte membrane
11/01/2011	US8049010 Using 4-4'-fluorophenyl-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-formaldehyde as raw material; cyanation to 4-4'-fluorophenyl-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-acrylonitrile; carbonylation, chain extension, hydrolysis, neutralization, decomposition, catalysis
11/01/2011	US8049008 Reverse-turn mimetics and method relating thereto
11/01/2011	US8048893 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
11/01/2011	US8048881 Pyrimidine derivatives and their use as P2Y12 receptor antagonists
11/01/2011	US8048874 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
11/01/2011	US8048542 Bis-phenanthroimidazolyl compound and electroluminescent device using the same
11/01/2011	CA2649521C Novel piperazine compound, and use thereof as hcv polymerase inhibitor
11/01/2011	CA2645257C Sulfonyl benzimidazole derivatives
11/01/2011	CA2545644C Melanocortin receptor agonists
11/01/2011	CA2521854C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
11/01/2011	CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
11/01/2011	CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
11/01/2011	CA2473839C Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
11/01/2011	CA2458813C Anti-cancer cyclopenta[g]quinazoline compounds
10/2011
10/27/2011	WO2011133750A1 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011	WO2011132684A1 Bis-carbazole derivative, material for organic electroluminescent element and organic electroluminescent element using same
10/27/2011	WO2011132683A1 Bis-carbazole derivative, material for organic electroluminescent element and organic electroluminescent element using same
10/27/2011	WO2011132048A1 Heteroaryl compounds as pde10a inhibitors
10/27/2011	WO2011131741A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors
10/27/2011	WO2011130918A1 Process for synthesizing imatinib
10/27/2011	WO2011130908A1 Substituted pyrimidines
10/27/2011	WO2011065800A3 Pyrimidine derivative, method for preparing same and pharmaceutical composition containing same
10/27/2011	WO2011059207A3 Arylpiperazine-containing purine derivatives and uses thereof
10/27/2011	WO2011056645A3 Poly(propargyl-l-glutamate) and derivatives thereof
10/27/2011	WO2011056511A3 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
10/27/2011	WO2011047319A8 Antimicrobial compounds and methods of making and using the same
10/27/2011	US20110263872 Radioactive isotope-labeled dye compound
10/27/2011	US20110263853 Hplc method for the analysis of bosetan and related substances and use of these substances as reference standards and markers
10/27/2011	US20110263846 NOVEL SILANIC PARA-AMINOBENZALMALONATE-SUBSTITUTED s-TRIAZINE COMPOUNDS AND PHOTOPROTECTIVE COMPOSITIONS COMPRISED THEREOF
10/27/2011	US20110263844 method for preparing macrocycles
10/27/2011	US20110263810 Process for preparing polymeric, ionic imidazolium compounds
10/27/2011	US20110263670 Novel polymorphs of sunitinib and processes for their preparation
10/27/2011	US20110263625 Hiv replication inhibiting pyrimidines
10/27/2011	US20110263623 Process for preparation of bosentan
10/27/2011	US20110263620 Quinoline compounds and their use for treating viral infection
10/27/2011	US20110263614 Novel compounds
10/27/2011	US20110263599 7-nonsubstituted indole mcl-1 inhibitors
10/27/2011	US20110263597 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/27/2011	US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011	US20110263566 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives and PBK Inhibitors Containing the Same

1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 626